Medicaid GLP-1 Coverage May Influence Diabetes Treatment Patterns | Retatrutide News

Medicaid's coverage of GLP-1 agonists for obesity may affect their use in diabetes treatment. This change could influence research and market dynamics f...
Market News · October 16, 2026